TransMedics Group, Inc. TMDX
2 trading plans running, 7 Form 144 notices for $4.0M
10-Q, 10-K and Form 144What TMDX's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Plans adopted or ended
Trading plans · XBRL, 10-Q and 10-K
From Nov 6, 2024 to Feb 2, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired.
| Insider | What | Date | Reported in |
|---|---|---|---|
| Edward Basile | Adopted 10b5-1 plan | Mar 4, 2026 | 10-Q May 5, 2026 |
| Tamer Khayal | Adopted 10b5-1 plan | Dec 11, 2025 | 10-K Feb 24, 2026 |
| James R. Tobin 2012 Trust | Adopted 10b5-1 plan | Sep 3, 2025 | 10-Q Oct 29, 2025 |
| Tamer Khayal | Adopted 10b5-1 plan | Dec 5, 2024 | 10-K Feb 27, 2025 |
| Edward Basile | Adopted 10b5-1 plan | Nov 6, 2024 | 10-K Feb 27, 2025 |
| Edward Basile Director |
Adopted 10b5-1 plan | – | 10-Q Nov 8, 2023 |
| James R. Tobin 2012 Trust |
Adopted 10b5-1 plan | – | 10-Q Oct 29, 2024 |
| Stephen Gordon Chief Financial Officer |
Adopted 10b5-1 plan | – | 10-Q Oct 29, 2024 |
| Stephen Gordon Chief Financial Officer |
Adopted 10b5-1 plan | – | 10-Q Nov 8, 2023 |
| Tamer Khayal Chief Commercial Officer |
Adopted 10b5-1 plan | – | 10-Q Nov 8, 2023 |
| Waleed Hassanein M.D., Chief Executive Officer |
Adopted 10b5-1 plan | – | 10-Q Nov 8, 2023 |
Show the other 3 plans
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 4, 2023.
Notices of planned sales
Form 144 · Form 144 XML, SEC
What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).
| Filed | Seller | Shares | Value |
|---|---|---|---|
| Nov 9, 2026 | JAMES R. TOBIN Director |
4,059 | $385K |
| Jun 15, 2026 | THOMAS GUNDERSON Director |
9,624 | $722K |
| Mar 4, 2026 | GERARDO P HERNANDEZ Officer |
7,236 | $1.1M |
| Mar 4, 2026 | STEPHANIE LOVELL Director |
1,193 | $178K |
| Mar 4, 2026 | DAVID WEILL Director |
3,571 | $524K |
| Dec 3, 2025 | DAVID WEILL Director |
5,000 | $693K |
| Nov 25, 2025 | ANIL P RANGANATH Officer |
3,000 | $436K |
From the Form 144 XML filed with the SEC, since Nov 25, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Sources
Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.
Also
Insider trades: the Form 4s for the sales these plans led to.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/TMDX/export.csv") into a cell.